April 8, 2014
Mixed open anticipated; RegMed’s investors are reducing net long exposure
April 7, 2014
RegMed risk bleeds uncertainty
April 2, 2014
Cytori’s (CYTX) CEO Calhoun OUT, “retires” Hedrick IN
March 28, 2014
Neuralstem (NYSE MKT: CUR) Early animal model shows dose dependent improvement - SELL
March 25, 2014
Higher open as trading hinges on indicators; RegMed’s retreat doesn’t seem to be setting off alarms
March 24, 2014
Speeders and leaders to laggards as NeoStem (NBS) is still the “prettiest” in the queue
March 24, 2014
BioLife Solutions (BLFS) digs out - BUY
March 21, 2014
Aastrom (ASTM) The wool is being pulled over investor’s eyes!
March 17, 2014
What’s the “tell” for the rest of the week?
March 17, 2014
RegMed tests a reflex rally
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.